facial myokymia
ORPHA: 2211062 Treatments Available
Overview
human disease
Available Treatments (2)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| carbamazepine | oral tablet 200mg, 400mg; extended-release tablet; oral suspension 100mg/5mL | FDA Approved | 11 | 7d |
| botulinum toxin type A Cold Chain | powder for injection 50 units, 100 units, 200 units per vial | FDA Approved | 9 | 14d |
Classification & Codes
Orphanet Code
ORPHA:221106facial myokymia
| Orphanet | ORPHA:221106 |
| Treatments | 2 drug(s) |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO